glutathione mutations in sclc patients Role of the Metabolic Pathway Lung Cancer Treatment and Prognosis: A Review Oncology Letters
Oncology Letters Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small cell lung cancer patients Annals of Oncology Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3



